Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hennes

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
European Urology|May 10, 2025
Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF): A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 TrialDavid C Chen, Abdullah Al-Khanaty, David Hennes, et al.
European Urology Focus|December 7, 2025
Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future DirectionsAbdullah Al-Khanaty, David Hennes, Marlon L Perera, et al.
European Urology|May 17, 2025
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled TrialDavid Hennes, Abdullah Al-Khanaty, David C Chen, et al.
Nature Reviews. Urology|September 15, 2025
End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detectionDavid Hennes, Abdullah Al-Khanaty, David C Chen, et al.
European Urology Focus|May 28, 2026
Avoiding Prostate Biopsy in Early Prostate Cancer Detection: From Liquid Biopsy to PSMA-PETAbdullah Al-Khanaty, David Hennes, Michael S Hofman, et al.
Cancers|January 10, 2026
Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future DirectionsKieran Sandhu, Abdullah Al-Khanaty, David Hennes, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 24, 2024
A double-blind, randomized, placebo-controlled trial of melatonin as an adjuvant agent for induction of labor: The MILO trialDiane Quach, Ben W Mol, Jamie Springer, et al.
European Urology Focus|June 28, 2026
Radioligand Therapy for Prostate Cancer - A Clinical Consultation GuideDavid Hennes, Abdullah Al-Khanaty, Mylestone Monna, et al.
BJU International|April 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancerAbdullah Al-Khanaty, David Chen, Jonathan Walbaum, et al.
Cancers|January 10, 2026
Using Artificial Intelligence as a Risk Prediction Model in Patients with Equivocal Multiparametric Prostate MRI FindingsAbdullah Al-Khanaty, David Hennes, Arjun Guduguntla, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
European Urology|May 10, 2025
Re: Effect of NeuroSAFE-guided RARP Versus Standard RARP on Erectile Function and Urinary Continence in Patients with Localised Prostate Cancer (NeuroSAFE PROOF): A Multicentre, Patient-blinded, Randomised, Controlled Phase 3 TrialDavid C Chen, Abdullah Al-Khanaty, David Hennes, et al.
European Urology Focus|December 7, 2025
Neoadjuvant Systemic Therapy in High-risk Localised Prostate Cancer: Current Evidence and Future DirectionsAbdullah Al-Khanaty, David Hennes, Marlon L Perera, et al.
European Urology|May 17, 2025
Re: Local Anaesthetic Transperineal Biopsy Versus Transrectal Prostate Biopsy in Prostate Cancer Detection (TRANSLATE): A Multicentre, Randomised, Controlled TrialDavid Hennes, Abdullah Al-Khanaty, David C Chen, et al.
Nature Reviews. Urology|September 15, 2025
End of the TRUS era: transperineal biopsy takes the lead in prostate cancer detectionDavid Hennes, Abdullah Al-Khanaty, David C Chen, et al.
European Urology Focus|May 28, 2026
Avoiding Prostate Biopsy in Early Prostate Cancer Detection: From Liquid Biopsy to PSMA-PETAbdullah Al-Khanaty, David Hennes, Michael S Hofman, et al.
Cancers|January 10, 2026
Neoadjuvant Therapies for Prostate Cancer-Current Paradigms and Future DirectionsKieran Sandhu, Abdullah Al-Khanaty, David Hennes, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 24, 2024
A double-blind, randomized, placebo-controlled trial of melatonin as an adjuvant agent for induction of labor: The MILO trialDiane Quach, Ben W Mol, Jamie Springer, et al.
European Urology Focus|June 28, 2026
Radioligand Therapy for Prostate Cancer - A Clinical Consultation GuideDavid Hennes, Abdullah Al-Khanaty, Mylestone Monna, et al.
BJU International|April 14, 2026
Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancerAbdullah Al-Khanaty, David Chen, Jonathan Walbaum, et al.
Cancers|January 10, 2026
Using Artificial Intelligence as a Risk Prediction Model in Patients with Equivocal Multiparametric Prostate MRI FindingsAbdullah Al-Khanaty, David Hennes, Arjun Guduguntla, et al.
Pageof 3